MyAverix Finance
SHG · Healthcare
Laobaixing Pharmacy (603883)
Pharmaceutical Retailers
Laobaixing Pharmacy (603883) is listed on SHG in the Healthcare sector. Industry: Pharmaceutical Retailers. As of 2026-03-29, reported market cap is $10.25B, P/E ratio is 24.55, net margin is 1.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603883
Laobaixing Pharmacy (603883) — FAQ
What is Laobaixing Pharmacy's market cap?
Laobaixing Pharmacy (603883) has a reported market cap of $10.25B (data as of 2026-03-29).
What is 603883's P/E ratio?
The price-to-earnings (P/E) ratio for Laobaixing Pharmacy (603883) is 24.55 (data as of 2026-03-29).
Does Laobaixing Pharmacy pay a dividend?
Dividend yield is not available in the current snapshot for Laobaixing Pharmacy (603883). Check the MyAverix Finance app for the latest dividend data.
What sector is Laobaixing Pharmacy in?
Laobaixing Pharmacy (603883) is classified in the Healthcare sector (Pharmaceutical Retailers industry).
What exchange is 603883 listed on?
603883 is listed on SHG.
What is Laobaixing Pharmacy's net margin?
Laobaixing Pharmacy (603883) reports a net margin of 1.9% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.